These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Fine needle aspiration biopsy of human renal transplants. Nishioka T; Negita M; Ikegami M; Imanishi M; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T Transplant Proc; 1992 Aug; 24(4):1551-3. PubMed ID: 1496655 [No Abstract] [Full Text] [Related]
44. Expression of ICAM-1 protein and ICAM-1 mRNA in human rejecting renal allografts. Sugito K; Morozumi K; Koide M; Fukuda M; Takeuchi O; Oda A; Kodera K; Oikawa T; Fujinami T; Takeda A Transplant Proc; 1995 Feb; 27(1):911-4. PubMed ID: 7879227 [No Abstract] [Full Text] [Related]
45. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children. Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630 [No Abstract] [Full Text] [Related]
46. The utility of fine-needle aspiration biopsy in organ transplantation. Yussim A; Shapira Z; Nakache R; Bar-Nathan N; Shmueli D; Shaharabani E; Burstein A; Or H; Buksenboim G; Lustig S Transplant Proc; 1992 Oct; 24(5):1880-1. PubMed ID: 1329285 [No Abstract] [Full Text] [Related]
47. Fine needle aspiration biopsy in renal transplant patients on prophylactic OKT3 treatment. Gonçalves LF; Rauber ML; Manfro RC; Prompt CA Transplant Proc; 1992 Dec; 24(6):3085-6. PubMed ID: 1466066 [No Abstract] [Full Text] [Related]
48. HLA-DR expression on tubular cells in kidney transplants. Almirall J; Sole M; Campistol JM; Bru C; Oppenheimer F; Andreu J; Revert L Transplant Proc; 1992 Feb; 24(1):69-70. PubMed ID: 1539349 [No Abstract] [Full Text] [Related]
49. Molecular activation markers in rejection diagnosis. von Willebrand E; Häyry P; Taskinen E Transplant Proc; 1996 Feb; 28(1):484-5. PubMed ID: 8644321 [No Abstract] [Full Text] [Related]
50. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts. Morozumi K; Thiel G; Gudat F; Mihatsch MJ Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404 [No Abstract] [Full Text] [Related]
51. Fine needle aspiration in study of glomerular pathology in human renal allografts. Yussim A; Ben-Bassat M; Shmueli D; Lustig S; Braslavsky D; Sosna Y; Shapira Z Transplant Proc; 1990 Aug; 22(4):1386-7. PubMed ID: 2389338 [No Abstract] [Full Text] [Related]
52. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection. von Willebrand E; Häyry P Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030 [No Abstract] [Full Text] [Related]
53. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients. Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405 [No Abstract] [Full Text] [Related]
55. Analysis of mRNA in renal allografts using polymerase chain reaction amplification. Williamson P; Allen RD; Chapman JR; Stewart GJ Transplant Proc; 1992 Feb; 24(1):205-7. PubMed ID: 1539249 [No Abstract] [Full Text] [Related]
56. Cyclosporine or rejection enhance secretion of von Willebrand factor in renal transplantation. Yussim A; Boksenboim G; Ben-Bassat M; Shmueli D; Lustig S; Bar Nathan N; Shaharabani E; Nakache R; Or H; Shapira Z Transplant Proc; 1994 Aug; 26(4):2032-3. PubMed ID: 8066661 [No Abstract] [Full Text] [Related]
57. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA? Takeda A; Morozumi K; Uchida K; Yokoyama I; Takagi H; Yoshida A; Fujinami T; Thiel G; Gudat F; Mihatsch MJ Transplant Proc; 1993 Feb; 25(1 Pt 1):515-7. PubMed ID: 8438396 [No Abstract] [Full Text] [Related]
58. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis. Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334 [No Abstract] [Full Text] [Related]
59. [Conversion of cyclosporin A therapy to conventional treatment with diagnostic use of aspiration biopsy in kidney transplantation]. Matl I; Lácha J; Lodererová A; Vítko S; Lánská V Cas Lek Cesk; 1997 Mar; 136(5):142-5. PubMed ID: 9221186 [TBL] [Abstract][Full Text] [Related]
60. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]